Proton-pump inhibitors and hypomagnesemic hypoparathyroidism.

PubWeight™: 2.22‹?› | Rank: Top 2%

🔗 View Article (PMID 17065651)

Published in N Engl J Med on October 26, 2006

Authors

Martin Epstein, Shaun McGrath, Florence Law

Associated clinical trials:

Effect of Magnesium Sulfate Infusion Rate on Magnesium Retention in Critically Ill Patients | NCT01426165

Articles citing this

Proton pump inhibitors and risk of fractures: a meta-analysis of 11 international studies. Am J Med (2011) 2.27

Omeprazole and refractory hypomagnesaemia. BMJ (2008) 1.43

The association between the use of proton pump inhibitors and the risk of hypomagnesemia: a systematic review and meta-analysis. PLoS One (2014) 1.25

Association of long-term proton pump inhibitor therapy with bone fractures and effects on absorption of calcium, vitamin B12, iron, and magnesium. Curr Gastroenterol Rep (2010) 1.23

Proton pump inhibitors and hospitalization with hypomagnesemia: a population-based case-control study. PLoS Med (2014) 1.20

Effects of proton pump inhibitors and electrolyte disturbances on arrhythmias. Int J Gen Med (2013) 1.14

Omeprazole decreases magnesium transport across Caco-2 monolayers. World J Gastroenterol (2011) 1.11

Omeprazole- and esomeprazole-associated hypomagnesaemia: data mining of the public version of the FDA Adverse Event Reporting System. Int J Med Sci (2012) 1.11

Hypomagnesemia Induced by Long-Term Treatment with Proton-Pump Inhibitors. Gastroenterol Res Pract (2015) 1.01

The impact of proton pump inhibitors on the human gastrointestinal microbiome. Clin Lab Med (2014) 0.97

Hypomagnesaemia associated with long-term use of proton pump inhibitors. Gastroenterol Rep (Oxf) (2014) 0.96

Out-of-hospital use of proton pump inhibitors and hypomagnesemia at hospital admission: a nested case-control study. Am J Kidney Dis (2013) 0.94

Omeprazole enhances the colonic expression of the Mg(2+) transporter TRPM6. Pflugers Arch (2013) 0.90

Proton pump inhibitor-induced hypomagnesemia: A new challenge. World J Nephrol (2012) 0.88

Hypomagnesemia in the intensive care unit: Choosing your gastrointestinal prophylaxis, a case report and review of the literature. Indian J Crit Care Med (2014) 0.88

Disorders of calcium and magnesium balance: a physiology-based approach. Pediatr Nephrol (2012) 0.87

Apical acidity decreases inhibitory effect of omeprazole on Mg(2+) absorption and claudin-7 and -12 expression in Caco-2 monolayers. Exp Mol Med (2012) 0.87

Proton-pump inhibitor use is associated with lower urinary magnesium excretion. Nephrology (Carlton) (2014) 0.86

Proton-pump inhibitor-induced hypomagnesemia: Current research and proposed mechanisms. World J Nephrol (2016) 0.85

Wernicke's Encephalopathy in a Patient with Peptic Ulcer Disease. Case Rep Med (2011) 0.83

'Lemonade Legs': Why do Some Patients Get Profound Hypomagnesaemia on Proton-Pump Inhibitors? Intest Res (2015) 0.83

Severe hypomagnesaemia due to lansoprazole. BMJ Case Rep (2009) 0.82

A Prospective, Placebo-Controlled Pilot Evaluation of the Effect of Omeprazole on Serum Calcium, Magnesium, Cobalamin, Gastrin Concentrations, and Bone in Cats. J Vet Intern Med (2016) 0.79

A patient on long-term proton pump inhibitors develops sudden seizures and encephalopathy: an unusual presentation of hypomagnesaemia. Case Rep Gastrointest Med (2012) 0.79

Dietary Inulin Fibers Prevent Proton-Pump Inhibitor (PPI)-Induced Hypocalcemia in Mice. PLoS One (2015) 0.79

The relationship between proton pump inhibitor use and serum magnesium concentration among hemodialysis patients: a cross-sectional study. BMC Nephrol (2015) 0.77

Managing peptic ulcer and gastroesophageal reflux disease in elderly Chinese patients--focus on esomeprazole. Clin Interv Aging (2013) 0.76

Proton pump inhibitor associated hypomagnasaemia - a cause for concern? Br J Clin Pharmacol (2016) 0.75

Proton pump inhibitor-induced hypomagnesemic hypoparathyroidism. Indian J Pharmacol (2015) 0.75

Proton Pump Inhibitor Prophylaxis After Gastric Bypass Does Not Cause Hypomagnesemia. Obes Surg (2016) 0.75

From hypomagnesaemia to Zollinger-Ellison syndrome: an adverse effect of a proton pump inhibitor. BMJ Case Rep (2014) 0.75

The Safety of Appropriate Use of Over-the-Counter Proton Pump Inhibitors: An Evidence-Based Review and Delphi Consensus. Drugs (2017) 0.75

Proton pump inhibitors use in hemodialysis patients and serum magnesium levels. Int J Clin Exp Med (2015) 0.75

Does long-term use of proton pump inhibitors cause hypomagnesaemia in Japanese outpatients? BMJ Open Gastroenterol (2015) 0.75

Proton Pump Inhibitor Use and Magnesium Concentrations in Hemodialysis Patients: A Cross-Sectional Study. PLoS One (2015) 0.75

Proton pump inhibitor-induced hypomagnesaemia and hypocalcaemia: case review. Int J Physiol Pathophysiol Pharmacol (2016) 0.75

The Role of Magnesium in Post-thyroidectomy Hypocalcemia. World J Surg (2016) 0.75

Omeprazole suppressed plasma magnesium level and duodenal magnesium absorption in male Sprague-Dawley rats. Pflugers Arch (2016) 0.75

Proton-pump inhibitors: understanding the complications and risks. Nat Rev Gastroenterol Hepatol (2017) 0.75

Association Between Proton Pump Inhibitor Use and Cognitive Function in Women. Gastroenterology (2017) 0.75

Proton Pump Inhibitors in Gastroesophageal Reflux Disease: Friend or Foe. Curr Gastroenterol Rep (2017) 0.75